Physician profile
Ashley Beade
NPI 1639830508
$1,530.34
in general payments reported to CMS, 2019-2025
19 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $36.54 · 2024: $376 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $231.19 | 2025 | Caplyta |
| Lilly USA, LLC | $168.99 | 2024-2025 | Zepbound, Mounjaro |
| Viiv Healthcare Company | $167.80 | 2025 | Apretude |
| Astrazeneca Pharmaceuticals LP | $163.82 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $103.33 | 2024-2025 | Trelegy Ellipta |
| Esperion Therapeutics, INC. | $86.11 | 2025 | Nexletol |
| Pfizer INC. | $84.40 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $80.76 | 2024 | |
| Dexcom, INC. | $70.34 | 2023-2024 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $66.85 | 2025 | Gemtesa |
| Abbvie INC. | $49.68 | 2025 | |
| Antares Pharma, INC. | $46.08 | 2024 | Xyosted |
| Verity Pharmaceuticals INC. | $44.97 | 2025 | Tlando |
| Exact Sciences Corporation | $42.49 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $39.35 | 2024-2025 | Repatha, Otezla, Repatha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $37.71 | 2023-2024 | Auvelity, Sunosi |
| Novo Nordisk INC | $16.05 | 2025 | Wegovy |
| Acella Pharmaceuticals, LLC | $15.94 | 2025 | NP Thyroid 60 |
| Tolmar, INC. | $14.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Beade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.